APA

Bamias A., Sotiropoulou M., Zagouri F., Trachana P., Sakellariou K., Kostouros E., Kakoyianni K., Rodolakis A., Vlahos G., Haidopoulos D., Thomakos N., Antsaklis A. & Dimopoulos M. A. (20120823). Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factor. : European journal of cancer (Oxford, England : 1990).

Chicago

Bamias A, Sotiropoulou M, Zagouri F, Trachana P, Sakellariou K, Kostouros E, Kakoyianni K, Rodolakis A, Vlahos G, Haidopoulos D, Thomakos N, Antsaklis A and Dimopoulos M A. 20120823. Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factor. : European journal of cancer (Oxford, England : 1990).

Harvard

Bamias A., Sotiropoulou M., Zagouri F., Trachana P., Sakellariou K., Kostouros E., Kakoyianni K., Rodolakis A., Vlahos G., Haidopoulos D., Thomakos N., Antsaklis A. and Dimopoulos M. A. (20120823). Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factor. : European journal of cancer (Oxford, England : 1990).

MLA

Bamias A, Sotiropoulou M, Zagouri F, Trachana P, Sakellariou K, Kostouros E, Kakoyianni K, Rodolakis A, Vlahos G, Haidopoulos D, Thomakos N, Antsaklis A and Dimopoulos M A. Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factor. : European journal of cancer (Oxford, England : 1990). 20120823.